Skip to search formSkip to main contentSkip to account menu

SYM001

Known as: SYM 001, SYM-001 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rozrolimupab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Development of mass spectrometry based techniques for the identification and determination of compositional variability in recombinant polyclonal antibody products.
Recombinant polyclonal antibodies are a new class of protein biologics, combining a defined number of target-specific antibodies… 
2008
2008
Sym001, the First Recombinant Polyclonal Rhesus-D Specific Antibody Product, Was Safe and Well-Tolerated in a Placebo-Controlled Randomized Phase I Trial.
Sym001 is the first compound in a new class of biopharmaceuticals in clinical development for the treatment of Immune… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)